Prof Brooks

New 3D Imaging Machine to Beat Prostate Cancer

Australian Prostate Cancer (APC), along with partner The Hospital Research Foundation (THRF) is proud to provide $250,000 to enable the purchase of a 3D scanner set to revolutionise the way prostate cancer is diagnosed and treated.

The 3D Histech Pannoramic confocal scanner will help Professor Doug Brooks from The University of South Australia School of Pharmacy and Medical Science and his team in their research to improve early detection of prostate cancer to ultimately save lives from the heartbreaking disease.

“We are developing several technologies to accurately visualize the disease process in prostate cancer patient samples to confirm diagnosis, help determine the size of the cancer, define tumour architecture and determine if the cancer is aggressive,” Prof Books says.

“We are also developing new imaging techniques that ultimately will mean we can visualize cancer in a live biopsy from a patient.

“Although these new imaging technologies have specific applications for prostate cancer, the technology will apply to other cancers, giving this project wider potential in cancer imaging.”

Now armed with this state-of-the-art imaging device thanks to APC and THRF, Prof Brooks can now translate the research into a pre-clinical study.

“A specific infrastructure requirement was identified that would boost our imaging capacity, so thanks to the generosity of APC and THRF, the equipment can now be used to facilitate the technology development in a pre-clinical study, ready for use in clinical setting,” Prof Books says.

APC CEO Paul Flynn is very proud to make the purchase of this scanner a reality which will go on to improve outcomes for so many men diagnosed with prostate cancer in the future.

“We are extremely proud to enable the purchase of the new confocal scanner to contribute to world-class research that is set to deliver tremendous impact in our community,” Mr Flynn says.

“This piece of equipment is essential in changing the way clinicians diagnose and predict the aggressiveness of prostate cancer. It will help to save lives.”

We look forward to keeping you informed on the progress of Prof Brook’s groundbreaking work.

Leave a Reply

Your email address will not be published. Required fields are marked *